Clinical Trial Update: Efficacy and the Safety of Regorafenib in Patients Aged More Than 70 Years With a Metastatic Colorectal Adenocarcinoma . [Phase 2]

View source ↗

Summary

Phase 2 trial updating efficacy and safety of regorafenib in patients over 70 with metastatic colorectal adenocarcinoma; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Adenocarcinoma
• Colorectal Cancer

Drugs mentioned

• Regorafenib (regorafenib)

Snippet

Sponsor: Federation Francophone de Cancerologie Digestive | Conditions: Colorectal Adenocarcinoma | Phase 2 | Status: COMPLETED | Results posted: 2024-02-23